Cannabis Report
Lithium
Home > Boards > US Listed > Medical - Drugs >

Fibrocell Science, Inc. (FCSC)

FCSC RSS Feed
Add FCSC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 8/15/2018 12:22:31 PM - Followers: 122 - Board type: Free - Posts Today: 0

Fibrocell Science, Inc. is a biotechnology company focused on the development of regenerative cell therapy for aesthetic, medical and scientific applications.

 

 

Welcome to the new Fibrocell Science, Inc. and our new web site. I am pleased to have this opportunity to share my enthusiasm with you as Fibrocell’s Chairman of the Board of Directors.

We have been extremely busy charting the course for Fibrocell as a biotechnology company focused on the power of regenerative fibroblast cells for aesthetic, medical and scientific applications.

We have a challenging and exciting path before us as we continue to prepare for the U.S. Food & Drug Administration response to the biologics license application (BLA) we submitted in March 2009 for the use of Laviv™ (azficel-T)*, Fibrocell Science’s lead therapy, for the treatment of moderate to severe nasolabial fold wrinkles. The FDA’s Cellular, Tissue and Gene Therapies Advisory Committee, which reviewed our therapy on October 9, 2009, voted 11 yes to 3 no that the data presented demonstrated efficacy, and 6 yes to 8 no that the data demonstrated safety, both for the proposed indication.

We are pleased to begin operations under Fibrocell Science, Inc., having reorganized the former Isolagen, Inc. and significantly reduced the company’s debt from US $81M to US $6M. We now look forward to an ambitious evaluation of our clinical priorities to maximize the potential use of our therapy in additional indications such as full-face rejuvenation, acne scars, burn scars and dental applications.

We have considerable work before us at Fibrocell Science, and we welcome the challenge. I join Fibrocell with extensive commercial experience from GlaxoSmithKline, where I most recently served as senior vice president, Pharmaceuticals and Vaccines. I am proud to have a strong management team helping guide this new company, including Declan Daly, former Isolagen chief executive officer, who was instrumental in our reorganization and remains committed to the company’s success.

Thank you for your interest in the new Fibrocell Science, Inc.

Sincerely,
David Pernock
Chairman
Fibrocell Science, Inc.

 

Fibrocell Therapy is an investigational autologous cell therapy. In the Fibrocell Science patented process, a patient’s own natural fibroblasts are extracted, multiplied and re-injected as personalized therapy. Fibroblasts are cells that contribute to the formation of connective tissue fibers. These matrix fibers are critical to the strength and elasticity of the skin.

Broadly, the regenerative effects of fibroblasts include:

- The ability to synthesize the extracellular matrix components and, thus, to improve skin texture,

- The secretion of matrix fibers, including collagen, and

- Playing a critical role in wound healing and tissue repair.

The Company prepares the Fibrocell Therapy through a streamlined process that begins with removing a small sample of cells from behind a patient’s ear and sending that sample to the Fibrocell cGMP facility. The process expands fibroblasts into tens of millions of new cells, which are then formulated into an autologous cellular therapy. Cells are frozen and used for multiple treatment sessions. The therapy is reintroduced into the patient’s skin by injection, which we believe results in an increase in the local fibroblast population, collagen formation and assists the body’s own regenerative healing process. In controlled clinical studies, a significant improvement in the appearance of nasolabial fold wrinkles was observed after injecting Fibrocell Therapy.

Regenerative fibroblast cells may have potential in use for broad aesthetic, medical and scientific applications. The Fibrocell Therapy for aesthetics, azficel-T, proposed brand name Laviv™, is currently under review by the FDA for the treatment of moderate to severe nasolabial fold wrinkles. Fibrocell Science, Inc. is planning to continue studies for additional aesthetic and therapeutic indications for azficel-T.

The company manufactures its cell therapy at a cGMP manufacturing facility in Pennsylvania.


Fibroblasts are cells that contribute to the formation of connective tissue fibers. Fibrocell's future scientific focus will be on regenerative medicine that leverages the direct and indirect therapeutic benefit of fibroblasts.

Fibrocell has submitted a biologics license application to the U.S. Food & Drug Administration (FDA) based on its Phase III clinical trials evaluating the efficacy and safety of its azficel-T in treating moderate to severe nasolabial fold wrinkles in patients older than 18 year of age.

In addition to wrinkle correction, Fibrocell has obtained statistically significant results in a Phase II/III acne scar clinical trial and a Phase II open label full face rejuvenation study.  Fibrocell also has results in early burn scars and periodontal disease studies.

 

 

Fibrocell Science, Inc. (OTC Bulletin Board: FCSC) is a biotechnology company focused on developing autologous cell therapies for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well its innovative cellular processing technology and manufacturing excellence.

Fibrocell Therapy is an investigational autologous cell therapy. In the Fibrocell Science patented process, a patient's own natural fibroblasts are extracted, multiplied and re-injected as personalized therapy to regenerate skin. Fibroblasts are cells that contribute to the formation of connective tissue fibers. The Fibrocell Therapy for aesthetics, azficel-T, proposed brand name Laviv™ is currently under review by the FDA for the treatment of moderate to severe nasolabial fold wrinkles.

Fibrocell Science, Inc. is planning to continue studies for additional aesthetic and therapeutic indications for its Fibrocell Therapy, which is manufactured at a cGMP cell therapy manufacturing facility at its headquarters in Pennsylvania.

 


OCTOBER 09, 2009
Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles

OCTOBER 06, 2009
Isolagen, Inc. Reorganizes as Fibrocell Science, Inc.

 

Cannabis Report
Lithium
FCSC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#6919   Decided to let go of this... FCSC was THREE-DAY-TRADER 08/15/18 12:22:31 PM
#6918   It moved higher into area I mentioned could THREE-DAY-TRADER 08/14/18 12:36:12 PM
#6917   $FCSC ~ Nice close for 8/10. It squeaked THREE-DAY-TRADER 08/10/18 04:54:27 PM
#6916   $FCSC recovering nicely after earnings this morning when THREE-DAY-TRADER 08/09/18 03:51:58 PM
#6915   That was a relatively very positive earnings report THREE-DAY-TRADER 08/09/18 08:21:58 AM
#6914   It looks more stable the past couple days THREE-DAY-TRADER 08/08/18 12:30:20 PM
#6913   Whatcha think now?? silkyballer 08/08/18 12:14:20 PM
#6912   I always assess a company's finances & cash, THREE-DAY-TRADER 07/30/18 04:34:26 PM
#6911   Thats why charting takes more than a few otterman 07/30/18 01:26:38 PM
#6910   It did another share offering filing 7/27 after THREE-DAY-TRADER 07/30/18 12:12:06 PM
#6909   Ok. otterman 07/29/18 07:03:13 PM
#6908   It was 'Basing' as of yesterday from 2.13 THREE-DAY-TRADER 07/27/18 04:31:32 PM
#6907   Sure would love to see that base youre otterman 07/27/18 02:36:59 PM
#6906   $FCSC ~ Appears to be starting a nice THREE-DAY-TRADER 07/26/18 03:21:01 PM
#6905   is this company under the umbrella of intrexon?...tia dirtydozen911 07/10/18 12:37:38 PM
#6904   If someone came in and purchased 1mil shares drczer 07/05/18 06:30:44 PM
#6903   If someone came in and purchased 1mil shares drczer 07/05/18 06:30:44 PM
#6902   Im DONE with this POS SELL jwest810 06/22/18 03:31:06 PM
#6901   Holding all shares...still zino 06/22/18 11:11:52 AM
#6900   * * $FCSC Video Chart 06-21-18 * * ClayTrader 06/21/18 05:02:22 PM
#6899   strong buying: Long! aristotelisonassis 06/21/18 03:19:36 PM
#6898   Shares Outstanding Just 7,7OO,OOO zino 06/21/18 03:16:52 PM
#6897   Great Day...Holding over night zino 06/21/18 03:15:03 PM
#6896   Fibrocell Announces Review of Strategic Alternatives zino 06/21/18 01:04:25 PM
#6895   Another Low Float Bio-Play !!! zino 06/21/18 12:47:54 PM
#6894   Yep Planopenny 06/08/18 10:36:45 AM
#6893   This has been a swing for me for Bearilla 06/08/18 10:14:55 AM
#6892   * * $FCSC Video Chart 05-25-18 * * ClayTrader 05/25/18 04:41:43 PM
#6891   Thanks !! FCSC Eagle1 05/25/18 01:03:52 PM
#6890   A 5 for 1 RS went into effect benchman 05/25/18 01:03:05 PM
#6889   Hi what did I miss? Fcsc Eagle1 05/25/18 12:57:02 PM
#6888   Looks like you didn't need to worry short benchman 05/25/18 10:07:33 AM
#6887   Well I already own it. Looks like benchman 05/25/18 09:06:01 AM
#6886   Long term I am not worried because the gator16 05/25/18 08:41:29 AM
#6885   Yes, I saw that. benchman 05/24/18 01:10:30 PM
#6884   Voted, approved, happening tomorrow, hence the BS pump Full Contact Yoga 05/24/18 01:06:20 PM
#6883   Remember this - you were warned. n3m3sis 05/24/18 09:24:55 AM
#6882   RS effective Tomorrow, massive failed scam. Full Contact Yoga 05/24/18 09:01:09 AM
#6881   RS vote was in a filing last month, benchman 05/22/18 03:56:13 PM
#6880   I listened to the whole call and did benchman 05/22/18 03:50:59 PM
#6879   Possible, not likely for an extended period without Full Contact Yoga 05/21/18 10:18:26 PM
#6878   Thank you for opportunity to load up b4 drczer 05/21/18 06:28:35 PM
#6877   RS vote in 2 days puts a damper Full Contact Yoga 05/21/18 02:51:29 PM
#6876   Oh I know it's good, but the stock benchman 05/21/18 09:35:20 AM
#6875   Read the news, it's good...meeting the 23rd as well Full Contact Yoga 05/21/18 09:31:48 AM
#6874   Not sure what they are saying on the benchman 05/21/18 09:02:38 AM
#6873   Hope the conf call is good benchman 05/21/18 08:40:30 AM
#6872   C.C. @ 8:30 this morning > up 20% crudeoil24 05/21/18 07:55:32 AM
#6871   Data looks better than ABEO data... Once we doncamel 05/19/18 02:04:38 PM
#6870   Data looks great, here is the link to benchman 05/19/18 06:35:03 AM
PostSubject